Trial · NCT01065454
Participant flow28
How many started, completed or left each group, period by period.
1 to 20 of 28
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment | STARTED | Riociguat (Adempas, BAY63-2521) up to 2 mg | 67 | |
| Treatment | STARTED | Riociguat (Adempas, BAY63-2521) up to 1 mg | 33 | |
| Treatment | STARTED | Riociguat (Adempas, BAY63-2521) Fixed 0.5 mg | 32 | |
| Treatment | STARTED | Placebo | 69 | |
| Treatment | COMPLETED | Riociguat (Adempas, BAY63-2521) up to 2 mg | 54 | |
| Treatment | COMPLETED | Riociguat (Adempas, BAY63-2521) up to 1 mg | 28 | |
| Treatment | COMPLETED | Riociguat (Adempas, BAY63-2521) Fixed 0.5 mg | 23 | |
| Treatment | COMPLETED | Placebo | 57 | |
| Treatment | NOT COMPLETED | Riociguat (Adempas, BAY63-2521) up to 2 mg | 13 | |
| Treatment | NOT COMPLETED | Riociguat (Adempas, BAY63-2521) up to 1 mg | 5 | |
| Treatment | NOT COMPLETED | Riociguat (Adempas, BAY63-2521) Fixed 0.5 mg | 9 | |
| Treatment | NOT COMPLETED | Placebo | 12 | |
| Follow up | STARTED | Riociguat (Adempas, BAY63-2521) up to 2 mg | 54 | |
| Follow up | STARTED | Riociguat (Adempas, BAY63-2521) up to 1 mg | 28 | |
| Follow up | STARTED | Riociguat (Adempas, BAY63-2521) Fixed 0.5 mg | 23 | |
| Follow up | STARTED | Placebo | 57 | |
| Follow up | Entering Follow-up | Riociguat (Adempas, BAY63-2521) up to 2 mg | 49 | |
| Follow up | Entering Follow-up | Riociguat (Adempas, BAY63-2521) up to 1 mg | 27 | |
| Follow up | Entering Follow-up | Riociguat (Adempas, BAY63-2521) Fixed 0.5 mg | 23 | |
| Follow up | Entering Follow-up | Placebo | 51 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01065454/flow